SCHEMBL29173495

SCHEMBL29173495

CNc1nc(Nc2ccc(=O)n(C(F)F)c2)c(C(=O)OC)nc1-c1cncc2c1ncn2C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205931 1.00 — —
SCHEMBL24944487 0.91 MKNK1 (0.34) —
SCHEMBL29173462 0.85 SYK (0.33) —
SCHEMBL30206133 0.85 SYK (0.33) —
SCHEMBL29173378 0.83 CYP1A2 (0.35) —
SCHEMBL30206107 0.83 CYP1A2 (0.35) —
SCHEMBL30205990 0.83 MLLT1 (0.31) —
SCHEMBL30206336 0.83 SYK (0.36) —
SCHEMBL29173448 0.83 SYK (0.36) —
SCHEMBL29173609 0.81 IKBKB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
Send feedback